Sounds to soothe the savage beast Ever since people have populated the planet buy generic montelukast 10mg on line asthma 2, they’ve turned to music for comfort order 4mg montelukast visa asthma breakthrough. From primitive drums to symphony orchestras generic montelukast 10 mg without a prescription asthma treatment using honey, sound elicits emotions — love, excitement, fear — and even relaxation. Music thera- pists work in hospitals, schools, and nursing homes using sounds to soothe. Visit any well-supplied music store or Web site and you’ll find an extensive array of possibilities. Many of these recordings boast of containing specially mixed music for optimal relaxation. Chapter 11: Relaxation: The Five-Minute Solution 191 Only the nose knows for sure Ever walk through a mall and smell freshly baked cinnamon rolls? We suspect that the smell of the delicacies is no accident; rather, we think that the bakers must pump the air up and out from around their ovens into the entire mall ventila- tion system, knowing the powerful effects of aroma. In addition to making you hungry, the cinnamon roll scent may also elicit pleas- ant emotions and memories. Perhaps it takes you back to Sunday mornings when your mother baked fresh rolls or to a pleasant café. If so, the aroma auto- matically brings back memories — no effort required on your part. Manufacturers of deodorants, lotions, powders, hair sprays, and air fresh- eners do the same, and you can explore the ability of aroma to calm your jangled nerves. Aromatherapy makes use of essential oils, which are natural substances extracted from plants. We can’t vouch for these claims, because good studies on their effects are lacking. However, the theory behind aromatherapy isn’t entirely wacky, because our bodies have nerves that transmit messages from the nose into the parts of the brain that control mood, memories, and appetite. If you’re physically sick, please consult a qualified doctor, because aromather- apy isn’t likely to cure you. However, if you want to experiment with various aromas to see if any of them help you relax, go for it. Preliminary studies have suggested that certain aromas may alleviate anxiety and decrease nicotine withdrawal symptoms and headaches. Consider the following aromatherapy scent suggestions, but be sure to shop around because prices can vary substantially. Besides, they smell pretty good, so put a few drops in your warm bath or on your pillow. However, one wonderful way to satisfy the need to be touched and relax at the same time is through a professional massage. Today, people flock to massage thera- pists to reduce stress, to manage pain, and to just plain feel good. This can be relaxing because, in addition to the massage that you get from the force of the water jets, the feel of the warm water that’s forced into the whirlpool and the sound of the water rushing around also has a calming effect. Everybody needs touching In the 1940s, many European babies ended up given regular massages gained more weight in orphanages. A shocking number of these than those who merely received standard orphans failed to grow or interact with others, medical care. Other studies by this research and some appeared to wilt away and die for no group have included normal babies, as well as discernible reason. Babies and children who receive failure to thrive appeared to be due to a lack a massage regularly have lower amounts of of human touch. In other words, the caregivers stress hormones and lower levels of anxiety provided nutrients but not contact. Other benefits that were identified include pain reduction, increased This early finding has been supported by attentiveness, and enhanced immune function. Just give them a moment to play with an idea, and they’re off on another anxiety trip. But the good news is that you can backtrack and rewind your mind to a calmer place. Guided imagery creates a calm place by using your imagination to put yourself into a state of relaxation and peace. For example, you might imagine hearing birds, smelling flowers, feeling a slight breeze, and enjoying the taste of chocolate in the middle of a beautiful meadow. Some people find that breathing exercises or progressive relaxation don’t get them sufficiently relaxed. From the time that she springs out of bed in the morning to the last gripping thought before restless sleep mercifully overtakes her, Shauna thinks. She replays every anxious moment at her job and dwells on each imagined error that she’s made during the day, turning it over and over in her mind. To reduce the stress and anxiety that saturate the scenes in her mind, she decides to seek the services of a counselor. The counselor teaches her several breathing techniques, but Shauna can’t hold back the ava- lanche of anxious images. She tries progressive muscle relaxation, massage, and then music and aromatherapy to no avail. When she tried other relaxation techniques, they failed because anx- ious images still filled her mind. With guided imagery, however, the richness of the peaceful experience pushed aside all other concerns. Letting Your Imagination Roam Some people, thinking of themselves as rather unimaginative, struggle to create pictures in their minds. These people generally feel uncomfortable with their drawing skills and have a hard time recalling the details of events they’ve witnessed. If so, using your imagination to relax and reduce your anxiety may not be the approach for you. Guided imagery encompasses more than the visual sense; it includes smell, taste, touch, and sound. We encourage you to give these exercises a shot, but all people have different strengths and weaknesses, and you may find that one or more of these exer- cises just don’t work for you.
The Implementation: actual and scheduled mean time deviation between actual and 00/0000 administration times* order 4 mg montelukast with mastercard asthmatic bronchitis wont go away, scheduled administration times did not Study Start: change significantly postimplementation 05/1997 (130 minutes vs buy montelukast 5mg amex asthma breathing exercises. Overall purchase 5 mg montelukast fast delivery asthma definition 7 killings, administration mistakes, 09/2004 pharmacy problems and prescribing Study End: problems accounted for 74% of all 04/2006 variances observed. In addition, after System therapy (days)*, the average duration of therapy was N = 87 patients Integrated Combination- decreased from 10. Combination 00/0000 system, Pharmacy escalation rate*, Mean Antimicrobial de-escalation rates were not Study Start: duration of statistically improved upon (67% vs. The average duration of Study End: Antimicrobial therapy therapy was decreased from 12. There was a large effect for Study Start: treatment; treatment of pneumococcal vaccination (12. Study End: warfarin, aspirin or adherence was significantly improved for 06/1996 ticlopidine; treatment of 13 standards (53. There were non significant Implementation: perioperative changes in the proportion of patients 00/0000 antibiotics, proportion of receiving perioperative antibiotics (64% Study Start: patients receiving vs. Supplementation of Mg at 00/0000 hypomagnesemia 1 hour was significantly improved, but not Study Start: treatment guidelines at 24 hrs. Supplementation of K was not 02/2001 synchronous alerts*, improved at 1 or 24 hrs. Synchronous Study End: compliance with alerts resulted in improved compliance at 03/2002 hypokalemia and 1 hr and 24 hrs for bot K and Mg hypomagnesemia supplementation (p <0. The results showed that overall Implementation: positive trends were minimally more 00/0000 prominent in the intervention arm (59. In the control group, Implementation: physicians spontaneously instituted the 00/0000 treatment that would have been Study Start: recommended in 17% of instances in 00/0000 which the recommendation was triggered Study End: but not issued. This 42% relative 00/0000 difference in compliance was statistically significant (p = 0. Sudden increase occurred Implementation: immediately after the start of the 09/1994 intervention (p <0. Other prescribing (3 drugs or drug classes and 4 age groups) did not differ across groups. In the control (prescriptions) group, baseline labs were requested for Implementation: 771 (39%) of the medications. In the 00/2000 intervention group, baseline labs were Study Start: ordered by clinicians in 689 (41%) of the 07/2003 cases. Recommendations for Implementation: regimens* changes to therapeutic regimens were 00/0000 followed in 28% of study events Study Start: compared to 13% of control events 00/0000 (p <0. N = 265 patients system, Pharmacy Inpatient hospital medications with Implementation: based cisapride* 01/1996 Study Start: 00/0000 Study End: 00/0000 C-137 Evidence Table 5. Significant randomized) differences between study and control Implementation: physicians also appear in 24 hour 00/0000 compliance (50. In cases in which a statistically significant difference was demonstrated, improved compliance favored the intervention group 71. Study Start: inhibitor started* 03/2004 Study End: 09/2006 C-140 Evidence Table 5. During the Study Start: intervention period the rate for 00/0000 computerized group was higher than the Study End: control (36% vs. During the intervention period the rate for computerized group was higher than the control (64% vs. Beta- N = 30 clinicians Change in diabetic blocker prescribed or contraindication Implementation: therapy if A1c > 7. Coronary artery disease reminders resulted in the recommended action for overdue items in 22% in the intervention group vs. Implementation: system duplication Resolution of discrepancies in frequency 00/0000 discrepancies* improved by 65% with the tool (18% vs. Total 00/0000 after discharge number of drugs reported by patients on Study Start: admission was 38% and 29% for paper 02/1998 based and electronic groups respectively. Study End: The figures on 10 days after discharge 05/1998 were 38% and 28% respectively. Frequency of Study Start: use was negatively 11/2005 associated with age Study End: (p <0. Hospital physicians found mean effort to use discharge software was more difficult than the usual care (6. The accuracy, usefulness, and consistency of checking patient identification improved as well. There Study End: were significant increases in 00/0000 each of the 3 subscales of efficacy, safety and access (p <0. Kralewski Prescribing e-Rx Ambulatory care, proportion of prescriptions Practice-level variables 244 (2008) Academic sent electronically explain most of the variance Design: Survey in the use of e-scripts by N = 93 physicians, although there physicians are significant differences in Implementation: use among specialties as 00/0000 well. General internists have Study Start: slightly lower use rates for e 09/2006 Rx and pediatricians have the Study End: highest rates. Larger 10/2006 practices and multispecialty practices have higher use rates, and five practice culture dimensions influence these rates; two have a negative influence and three (organizational trust, adaptive, and a business orientation) have a positive influence. Improved self- 00/0000 Inpatient hospital much and how often the reported perceptions of clear Study Start: based medications were to be instructions on what 09/2004 taken, other instructions on medications to take (p = Study End: taking the medication, 0. Healthcare provider Physician assistants and nurse practitioners reported that patients had clearer instructions on discharge (p = 0. Characteristics related Study Start: to the quality of care, such as 00/1993 reducing error or giving Study End: information, were less 00/1995 strongly correlated with overall satisfaction (r = 0. These problems human factors centered on text psychology) presentation, too much Implementation: information/too many 02/2004 decisions at one time, color Study Start: scheme (monochromatic 00/0000 blue/grey with red used as Study End: accent and not to note 00/0000 caution or problems). Groups did not differ physicians at 2 Pharmacy for use by gender, use of a hospitals. High and intermediate users were 3 times as likely to believe that the user interface of the system supported their work flow. Similarly, 19% of low users, 31% of intermediate users, and 45% of high users believed that entering orders into the system was faster than writing orders. Patients anticipated they would find their overall experience of being involved in the study challenging (32%), rewarding (62%), educational (41%) and interesting (63%). Postintervention, patients reported positive experiences of being involved in the study, describing their experience as interesting (80%), valuable (77%) and educational (34%).
Similarly discount montelukast 10mg line asthma 7 year old, in the extract below buy montelukast 5 mg otc asthma in babies, Cassie indicates that despite knowledge of the serious side effects associated with antipsychotic medication safe montelukast 4mg asthma doctor specialist, the benefits of adherence in terms of enhancing her life outweigh these: Cassie, 04/02/2009 L: How do you feel I guess generally, overall about taking antipsychotic medication? C: I don’t like it, coz I read an article in the paper years ago that it takes about 5 years off your life. But then I looked at it the other way, if I didn’t take it, I wouldn’t have a life so I take it. Specifically, Cassie highlights that antipsychotic medication “takes about 5 years off your life”. Whilst she evaluates taking medication negatively (“I don’t like it”), she acknowledges that if she “didn’t take it”, she “wouldn’t have a life”. Whilst it is unclear whether she is implying that she 207 was suicidal when symptomatic, or whether her functioning was so poor that she could not participate in life, she emphasises the significantly negative, potentially fatal, impact of non-adherence on her life and associates this with her adherence (“so I take it”). The side effects code and codes related to the effectiveness of medication in treating symptoms incorporated foci on the bodily experiences associated with taking medication. The impact that various medication-related factors exerted on consumers’ functioning and their everyday lives was also apparent throughout the analysis. Whilst the route of medication was not commonly discussed by interviewees, some indicated that a long-acting depot route enabled them to overcome the inconveniences associated with having to take medication on a daily basis. A depot route was also constructed as helping consumers overcome unintentional non-adherence, through forgetfulness. Regarding storage, some interviewees indicated that medication packs and dosette boxes enabled them to keep track of their adherence and at times, enabled them (or others) to intervene by addressing missed dosages. A wide range of side effects were reported and, whilst they were often implicated in non-adherence, interviewees’ tolerability of side effects varied, often depending on how much side effects hindered their lives. Consistent with past research, some interviewees stated that they experienced 208 particularly intolerable side effects following being administered high dosages of medication, or when taking multiple medications, which often occurred during hospitalisation and frequently resulted in discontinuation. The effectiveness and ineffectiveness of medication in treating symptoms were associated with adherence and non-adherence respectively. However, in line with previous findings, interviewees frequently talked about side effects and efficacy collectively. That is, interviewees tended to weigh up the benefits of medication (treating symptoms and the associated impact on life) and the costs associated with medication (side effects and associated impact on life) in the context of expressing their past or present stances on adherence. Service-related factors were frequently raised in interviewees’ talk about their experiences with antipsychotic medication. Interviewees often talked about both past and present experiences with service providers and services in relation to their adherence at different stages and how services could be utilized or altered to assist consumers to achieve better outcomes. The most common service-related factor raised by interviewees in this study was the relationship between consumers and prescribers, referred to as the therapeutic alliance, which has been well established in the literature as an influence on adherence (i. The proceeding analysis helps to contextualize previous research findings, as interviewees elaborate how, and which, important elements of relationships with prescribers (and occasionally other service providers) influence their adherence choices. Service providers, such as case managers and peer workers, and other services, including community centres, were also raised in interviewees’ talk in relation to medication adherence. These services are not commonly individually associated with adherence in the literature, however, they may have been discussed in relation to interventions and featured in some recovery research (i. Interviewees consistently spoke positively about peer worker services and community centres. Peer worker and community centre services were typically represented as supporting adherence and consumers’ general well-being by interviewees and, moreover, greater peer worker involvement in the treatment model was encouraged. The service-related factors analysis commences with the therapeutic alliance code, which concludes with a sub-code in relation to non-adherence as an expression of resistance. Following on from this, a code in relation to peer workers and community centres is presented. Furthermore, interviewees frequently supported an increased role for peer workers in interventions to address poor adherence amongst consumers. Most of the interviewees in the present study were prescribed medication by psychiatrists and the rest were prescribed medication by general practitioners. Some previous attempts have been made to identify the essential elements of a positive therapeutic alliance. In their analysis of service users’ views of psychiatric treatments, Rogers and Pilgrim (1993) identified belief in treatment, the maintenance of hope, willingness to share information, avoidance of confrontation and punishment, mutual involvement in decision- making and accessibility to the consumer on the consumer’s terms as essential components of a positive therapeutic alliance. Regarding 211 adherence, studies have highlighted the importance of collaboration (i. It has also been recommended that health- care providers involve family members in treatment decisions to enhance adherence (Blahski et al. Moreover, studies have indicated that there may be a negative effect on adherence if service providers fail to empathise with consumers’ reasons for non-adherence, or regard the consumer’s illness as beyond repair (Weiden et al. This code is organised into sub-codes that reflect the elements of the therapeutic alliance that were considered important by interviewees in the present research. Specifically, consistent with previous findings, interviewees indicated that the power relations that operate within the therapeutic alliance influenced their adherence. They tended to contrast a collaborative alliance, whereby treatment decisions were shared, with an authoritative alliance, whereby interviewees perceived their prescribers to have control over their treatment regimens. Additionally, interviewees indicated that prescribers’ interest in their experiences (as reflected through in-depth questioning) and their knowledge of relevant background information were important to them. Most importantly, interviewees overwhelmingly reported that the degree to which their prescribers tailored their medication regimens to their individual circumstances, including symptom fluctuations, stressful situations and lifestyle factors, influenced their adherence. Extracts that relate to these aspects of the therapeutic alliance are presented below. Whilst collaboration is considered a cornerstone of a positive therapeutic alliance, the degree to which collaboration actually takes place in clinical practice has been challenged by some research. Similarly, in their qualitative interview studies involving people with psychiatric illnesses including schizophrenia, Sharifet al. Interviewees in the present study consistently highlighted the importance of collaboration. Their accounts also frequently indicated that a collaborative therapeutic alliance does not reflect their actual experiences.
One hundred clinicians were randomly assigned Study Start: 01/2000 either to a control group or to a group that received the alert when Study End: 02/2000 viewing the electronic medical record of eligible patients cheap 10 mg montelukast asthma symptoms after bronchitis. Comparisons were made on the proportion of patients no longer eligible for alert at end of month cheap 4 mg montelukast with mastercard asthma treatment non steroidal. Of the 2 cheap 10 mg montelukast with visa hidden asthma definition,506 patients studied, 2,361 were followed up beyond the index hospitalization. Physicians received 1 clinicians email per intervention patient facilitating statin prescription and Implementation: 07/2003 monitoring. Outcomes were changes in statin prescription, and Study Start: 07/2003 cholesterol levels across times during the 1-year trial. Differences in the proportion of visits resulting in lab testing Implementation: 00/2000 within 14 days were analyzed. The clinics included 366 physicians, Study Start: 07/2003 2,765 patients and 3,673 events requiring lab monitoring test orders. Both performance indicators and prescription volumes were calculated as the main outcome measures. Reminders were generated if patients were on a target 1,922 geriatric patients and medication for at least 365 days with no record of a relevant lab test 303 primary care physicians within the previous 365 days. Each patient visit (n = 794 visits patients by 257 patients) was regarded as an independent event during the 8 Implementation: 00/0000 month trial. Computer reminders consisted of paper reports printed Study Start: 00/0000 for each patient encounter. The reminder system was within the Study Start: 05/2004 pharmacy information system. We compared patients in the intervention and control groups for changes in processes and outcomes of care from the year preceding the study through the year of the study by intention-to-treat analysis. Power analysis performed for change in HbA1c levels which is abstracted as the primary outcome. The primary venues N = 712 patients Academic for this study were the general medicine practice and the Wishard Implementation: 00/0000 Memorial Hospital outpatient pharmacy. The study assessed the Study Start: 01/1994 effects of evidence-based treatment suggestions for hypertension Study End: 05/1996 made to physicians and pharmacists using a comprehensive electronic medical record system. The computer-based ordering system generated care suggestions for both intervention and control groups; All hypertension care suggestions for intervention patients were displayed as “suggested orders” on physicians’ workstations when they wrote orders after patient visits. There were 4 groups: control, physician intervention, pharmacy intervention and both interventions. Randomized, controlled trial on the N = 24 practice teams general medicine inpatient service of an urban, university-affiliated Implementation: 10/1991 public hospital. Study subjects were 78 house staff rotating on the 6 Study Start: 10/1992 general medicine services. The intervention was reminders to Study End: 03/1993 physicians printed on daily rounds reports about preventive care for which their patients were eligible, and suggested orders for preventive care provided through the physicians’ workstations. Compliance with preventive care guidelines and house staff attitudes toward providing preventive care to hospitalized patients were the main outcome measures. N = 86 physicians on 6 During the 6-month trial, reminders about corollary orders were services (services presented to 48 intervention physicians and withheld from 41 control randomized) physicians in a general medicine public teaching hospital. All Implementation: 00/0000 physicians had access to the guidelines, intervention physicians Study Start: 10/1992 received the onscreen reminders that they could easily accept, reject Study End: 04/1994 or modify; for control physicians the computer tracked the number of time corollary orders would have been triggered. Compliance rates were compared immediately (at the time of the trigger order), at 24 hours post trigger order and within hospital stay compliance rates. In all there were 7,394 trigger orders and 11,404 suggestions for corollary orders. Compliance with guidelines for lab monitoring was compared Study End: 10/2003 between the groups, rates among the different drugs were also compared. Length of hospital stay, adverse events, mortality and antibiotic Study Start: 05/2004 costs, including costs related to future antibiotic resistance, were Study End: 11/2004 compared for all patients. N = 242 Patients Academic Intervention physicians also received e-mails asking whether aspirin Implementation: 00/0000 was indicated for each patient. If so, patients received a mailing and Study Start: 10/2004 nurse telephone call addressing aspirin. The primary outcome was Study End: 03/2005 self reported regular aspirin use in 242 patients. Study End: 08/2006 department 9,111 study-related orders by 778 providers were entered for 2,981 patients. Group of 10 pulmonologists and 10 primary care Implementation: 03/2000 physicians (who recruited 98 and 100 patients with persistent asthma Study Start: 10/1999 respectively) were randomized to intervention and control. Costs were calculated from the consumption of resources registration for 12 months and determined the cost effectiveness of intervention by an incremental analysis. N = 30 patients Study patients received a Bluetooth enable blood glucose meter, a Implementation: 00/0000 cell phone and WellDoc’s proprietary diabetes management Study Start: 00/0000 software, Diabetes Manager. Average decrease of A1c and physicians change of medication were measured and compared between the groups. The objective of the study was to determine whether N = 9,565 patients, 10,169 computerized alerts were effective at increasing the percentage of dispensing ambulatory patients with laboratory monitoring at initiation of drug Implementation: 00/0000 therapy. The primary outcome measure was the percentage of drug Study Start: 09/2002 dispensing with baseline laboratory monitoring. Alerts were triggered Study End: 12/2003 by a dispensing of one of 15 target drug or drug classes. The alert was sent electronically to the Clinical Pharmacy Call Center daily if lab tests were not completed. This team of pharmacists contacted patients by phone to remind them their test was due or to order the tests if the physician did not do so. The intervention therefore had 2 stages; the alerting of the pharmacist by the computer and the phone follow-up by the pharmacist. An alert generated in the pharmacy system prevented printing of the label until a pharmacist intervened by contacting prescribing clinicians by phone. N = 11,100 women Measured by the proportion of pregnant women dispensed a Implementation: 00/0000 category D or X medication and the total number of first dispensing Study Start: 01/2003 of targeted medications. Alerts were sent to pharmacists who had to Study End: 04/2003 review prescription and contact prescriber before the prescription label would print.